Approval · Notice of Compliance 13770 · 2012
CLOPIDOGREL: Notice of Compliance 13770
Issued October 25, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13770
- Date
- October 25, 2012
- Company
- Pro Doc LimiteeLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer an product name
- Therapeutic class
- Platelet aggregation inhibtor
- Canadian reference product
- PLAVIX (Sanofi-Aventis Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CLOPIDOGREL | 02394820 | Marketed |
Medicinal ingredients
- CLOPIDOGREL BISULFATE 75 MG per TAB